Positive results of preclinical studies confirm the potential of Neurizon’s lead drug candidate NUZ-001 to be a ...

I pray that she carries the love that she felt tonight every day that she has," said friend Rita Monteiro, who organized the ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

Zac Brown Band's John Driskell Hopkins is turning his battle with ALS into a mission to help others: "When you're given a ...

Almost all cases of ALS and half of frontotemporal dementia (FTD) cases are linked to dysfunction in a protein TDP-43.

Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...

In a landmark continuing collaboration, Answer ALS and Cedars-Sinai have announced the completed availability of the largest amyotrophic lateral sclerosis (ALS) patient-based induced pluripotent stem ...

Tal Newberry passed from Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease on Christmas Day in ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...

The newly combined company will focus on moving Kadimastem's AstroRx, NLS's DOXA platform, and other therapies through ...